title: 5-(4-Methyl-phen-yl)-2,3-diphenyl-5,6-dihydro-imidazo[1,2-c]quinazoline.
abstract: In the title compound, C(29)H(23)N(3), the pyrimidine ring adopts an envelope conformation. The dihedral angle between the phenyl rings attached to the pyrimidine-ring double bond is 62.09 (7)°. In the crystal, mol-ecules are linked by N-H⋯N hydrogen bonds, forming extended chains in the c-axis direction.
authors: Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu 214063, People's Republic of China.
authors: Jiankang
authors: J
authors: Zhang
authors: Xiaofen
authors: X
authors: Qin
authors: Xingqin
authors: X
authors: Zhou
references: Mol Pharmacol. 1991 Nov;40(5):699-706
references: 1658605
references: Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
references: 18156677
references: Anticancer Drug Des. 1994 Dec;9(6):527-38
references: 7880377
references: Anticancer Drug Des. 1994 Feb;9(1):51-67
references: 8141966